Core Viewpoint - The company, Giant Medical Holdings (02393), anticipates a significant decline in its unaudited consolidated net profit for the six months ending June 30, 2025, projecting it to be no less than RMB 10 million, compared to approximately RMB 1.093 billion for the six months ending June 30, 2024 [1] Group 1 - The expected decline in net profit for the mid-2025 period is primarily attributed to the absence of a profit of approximately RMB 1.083 billion recognized in the mid-2024 period from the redemption of the company's originally scheduled 2026 due preference notes at a discount [1] - Additionally, the decrease in revenue from the medical products segment is also a contributing factor to the anticipated reduction in profit [1]
巨星医疗控股(02393)发盈警 预计中期综合纯利将大幅减少至不少于1000万元